Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EPZM

Epizyme (EPZM) Stock Price, News & Analysis

Epizyme logo

About Epizyme Stock (NASDAQ:EPZM)

Advanced Chart

Key Stats

Today's Range
$1.47
$1.47
50-Day Range
$1.47
$1.52
52-Week Range
$0.41
$5.80
Volume
7,960 shs
Average Volume
3.23 million shs
Market Capitalization
$247.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EPZM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epizyme and its competitors with MarketBeat's FREE daily newsletter.

EPZM Stock News Headlines

bluebird bio Inc BLUE
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Epizyme: Q2 Earnings Insights - Benzinga
See More Headlines

EPZM Stock Analysis - Frequently Asked Questions

Epizyme, Inc. (NASDAQ:EPZM) announced its quarterly earnings data on Tuesday, November, 9th. The biopharmaceutical company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.48) by $0.16. The firm's quarterly revenue was up 45.8% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Epizyme investors own include Novavax (NVAX), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), Pfizer (PFE), Applied Materials (AMAT) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/09/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EPZM
CIK
1571498
Employees
250
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$251.12 million
Net Margins
-391.90%
Pretax Margin
-391.80%
Return on Equity
-2,459.33%
Return on Assets
-69.74%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.35
Quick Ratio
5.19

Sales & Book Value

Annual Sales
$37.43 million
Price / Sales
6.61
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.54) per share
Price / Book
-2.72

Miscellaneous

Outstanding Shares
168,329,000
Free Float
128,968,000
Market Cap
$247.44 million
Optionable
Optionable
Beta
-0.41

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:EPZM) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners